...
...
Next Story

India to make 300 million doses of Sputnik V in 2021, says Russian Direct Investment Fund chief

The Russian Direct Investment Fund (RDIF) has partnered with Dr. Reddy’s Laboratories Limited and pharma firm Hetero for clinical trials and distribution of the Russian Covid-19 vaccine in India.

Updated on: Dec 18, 2020, 15:30:13 IST
Hindustan Times, New Delhi | By
Prefer HTon Google
Advertisement

India will produce about 300 million doses of Russia’s Sputnik V vaccine against the coronavirus disease (Covid-19) next year, the head of the Russian Direct Investment Fund (RDIF), which has partnered with Dr Reddy’s Laboratories Limited and pharma firm Hetero for clinical trials and distribution of the two-shot vaccine in India, has said.

A Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Thursday, Dec. 10, 2020 (AP Photo/Pavel Golovkin)
A Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Thursday, Dec. 10, 2020 (AP Photo/Pavel Golovkin)

Click here for full Covid-19 coverage

“In India, we have agreements with four large manufacturers. India will produce about 300 million doses or more of the vaccine for us next year,” RDIF’s chief executive officer Kirill Dmitriev was quoted by Tass news agency as saying. “The Russian Sputnik V will be actively produced in the world and we see that this is built on a safe platform based on the human adenovirus,” Dmitriev said in an interview to Rossiya 24 TV channel.

The Russian embassy in India had said on Friday, quoting Dmitriev, that Russia is testing the first samples of Sputnik V that were produced in India.

On Thursday, President Vladimir Putin had said the vaccine is “over 95% effective.” Developed by the Gamaleya Institute of Epidemiology and Microbiology, Sputnik V is claimed by Russia to be the world’s “first Covid-19 vaccine” and was registered by the country’s health ministry in August.

In November, during the virtual BRICS summit hosted by Russia, Putin had said Sputnik V could be produced in both India and China. India and China, along with Russia, are members of the five-nation BRICS, with Brazil and South Africa being the remaining two.

Also Read | India may start producing Russia’s Covid-19 vaccine Sputnik V, says Putin

India is the second worst-affected country in the world, behind the United States, with Covid-19 cases in excess of 9.9 million and Russia has the fourth highest tally of infections. The world’s largest country has a caseload in excess of 2.7 million, according to a tally maintained by worldometers.

According to Johns Hopkins University, the Covid-19 caseload across the world is nearing 75 million cases and stands at 74,952,221 and that there have been 1,662,127 related deaths till date.

(With agency inputs)

 
Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.
Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe